Produktinformation
MK-3697 is a research chemical that has shown various biological effects in bioassays. It has been found to reduce urea nitrogen levels and increase gamma-aminobutyric acid (GABA) concentrations, indicating its potential in the treatment of hepatic steatosis. MK-3697 has also demonstrated inhibitory activity against adenine-induced liver fibrosis, suggesting its role in preventing liver damage. Additionally, this compound exhibits triterpenoid saponin-like properties and may have applications in the development of new therapeutic agents. The ultra-low glycine amide content of MK-3697 makes it suitable for molecular docking studies and recrystallization experiments. Furthermore, MK-3697 has been investigated for its interaction with the 5-hydroxytryptamine subtype receptor, providing insights into its potential as a modulator of serotonin signaling pathways.
